Amit Kumar Jha
10Patents
1h-index
22Co-inventors
46Inventor score
Filing activity: Mar 16, 2012 → Mar 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10537562B2 | Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof | Human Necessities | 2 | Active |
| US10000582B2 | Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11331324B2 | Modified release suspension of eslicarbazepine | Human Necessities | 0 | Active |
| US9597412B2 | Injectable delivery system for heparan-binding growth factors | Human Necessities | 0 | Active |
| US10500138B2 | Polyphenols/PEG based hydrogel system for a dental varnish | Human Necessities | 0 | Active |
| US9827272B2 | Growth factor sequestering and presenting hydrogels | Chemistry; Metallurgy | 0 | Active |
| US10150948B2 | Compositions and methods for producing and administering brown adipocytes | Chemistry; Metallurgy | 0 | Active |
| US10918630B2 | Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof | Human Necessities | 0 | Active |
| US11642351B2 | Eslicarbazepine suspension | Human Necessities | 0 | Active |
| US9492484B2 | Cardiosphere derived cell population and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.